DN-DESIGN.DE

www2.abx-cro.com

data management - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/data-management

Phase II - III. Our data management team brings their extensive industry experience to any project. Combining their expertise with our robust CDMS and IT infrastructure, it allows our clients the peace of mind that their data will be captured and validated in strict accordance with industry standards and FDA regulations. Middot; eCRF, paper CRF or Hybrid solution. Middot; CRF Design / guidelines. Middot; Double Data entry (paper). Middot; Medical Coding. Middot; CDISC compliant databases. Radioimmunother...

www2.abx-cro.com

PET studies - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/pet-studies

Phase II - III. Phase 0 studies, also called micro-dosing studies, are a new regulatory category, guided by the EMEA (CPMP/SWP/2599/02, 2003) and FDA (Exploratory IND draft, 2005) allowing to perform human studies with a considerably reduced tox package, compared to a conventional first in human study, provided that not more than 100 µg substance are administered. ABX-CRO offers different PET study types. F]FDG, drug effects on metabolism can be studied. Using [. PET tracer development studies. For PET r...

www2.abx-cro.com

abx-direct - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/abx-direct

Phase II - III. Image Data Management for. Clinical trials made easy! Raquo; Secure, encrypted image transfer and storage. Raquo; Easy remote installation worldwide. Raquo; 21 CFR Part 11 compliant solution. Raquo; Direct DICOM transfer from PACS to. Developed specifically for use in multicenter clinical trials, ABX-DIRECT addresses all your needs and takes away all your headaches related to image data management in clinical trials. Raquo; Transfer images from clinical sites to. The Image Core Lab (ICL).

www2.abx-cro.com

phase II - III - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/phase-II

Phase II - III. Phase II - III. International multicentre phase II and III trials are challenging for the sponsor, due to differences in language, health care systems, regulatory environments, medical practice, and cultural background. With our own or collaborative offices in Australia, Brazil, France, Italy, Japan, South Africa, Switzerland, and the US, and a network of home based pharmaceutical research experts, we provide global clinical coverage, at highest quality, affordable not only for big pharma.

www2.abx-cro.com

phase I - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/phase-I

Phase II - III. ABX-CRO is one of the few contract research organisations with extensive experience to conduct phase I trials also with radiopharmaceuticals. Radiation safety issues, regulatory requirements and nuclide logistics need to be dealt with. As commercial phase I units are not equipped to handle radiopharmaceuticals, such trials need to be conducted in academic institutions. ABX-CRO has developed special expertise to fully implement GCP in an academic environment. The clinical unit performs:.

www2.abx-cro.com

consultancy - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/consultancy

Phase II - III. ABX-CRO has successfully conducted several EMEA Orphan Status applications for both diagnostic and therapeutic products. Design of Drug Development plans in compliance with latest regulatory requirements, or implementation of scientific advice meetings with European health authorities or the US FDA, are among the most sensitive contract services in the drug development industry. Version date: 19-09-2016 04:08:53. URL: http:/ www2.abx-cro.com. Blasewitzer Straße 78-80. Oncology services mo...

www2.abx-cro.com

preclinical - ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

http://www2.abx-cro.com/en/preclinical

Phase II - III. A wealth of new drug targets has been discovered in recent years, and many more to come still lie buried in the immense data generated by the human genome project, and modern proteomics. While pharmaceutical companies race to develop ligands for such targets, evidence for the pathophysiological relevance of such targets for successful therapeutic interventions often remains speculative. Animal PET and MRI. Version date: 19-09-2016 04:08:53. URL: http:/ www2.abx-cro.com. Radiopharmaceutica...

hensel-immobilien.com

Impressum - Hensel Immobilien Dresden

http://www.hensel-immobilien.com/impressum.html

Anbieter nach 5 TMG (Telemediengesetz). Telefon: 49 (351) 899 68 58. Telefax: 49 (351) 899 68 58. Mobile: 0172 / 797 876 0. E-Mail: info@hensel-immobilien.com. Erlaubnis nach 34c Gewerbeamt Landeshauptstadt Dresden. Der Autor übernimmt keinerlei Gewähr für die Aktualität, Korrektheit, Vollständigkeit oder Qualität der bereitgestellten Informationen. Haftungsansprüche gegen den Autor, welche sich auf Schäden materieller oder ideeller Art beziehen, die durch die Nutzung oder Nichtnutzung der dargeboten...

salumeria-dresden.de

Impressum | Salumeria DresdenSalumeria Dresden

http://salumeria-dresden.de/Salumeria-Blog/impressum

SALUMERIA - Italienische Spezialitäten. Angaben gemäß 5 TMG:. Salumeria – italienische Spezialitäten. Quellenangaben für die verwendeten Bilder und Grafiken:. Http:/ www.marabotto.it. Http:/ www.dn-design.de. Http:/ www.werbefotografen-dresden.com/. Weitere Bilder von unseren Herstellern:. Der Nutzung von im Rahmen der Impressumspflicht veröffentlichten Kontaktdaten durch Dritte zur Übersendung von nicht ausdrücklich angeforderter Werbung und Informationsmaterialien wird hiermit ausdrücklich widersproche...